Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J MONTERO

Showing results (421-430 of 551) with videos related to

Pageof 56
Sort By:
Nature Medicine|June 13, 2006
Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunctionVincent Sauzeau, María A Sevilla, Juan V Rivas-Elena, et al.
Menopause (New York, N.Y.)|September 16, 1999
Models of intervention in menopause: proposal of a holistic or integral modelJ C Olazábal Ulacia, R García Paniagua, J Montero Luengo, et al.
Breast Cancer Research and Treatment|June 6, 2014
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancerTadeu Ambros, Simon B Zeichner, John Zaravinos, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2007
Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine modelC Marcela Díaz-Montero, Sabry El Naggar, Amir Al Khami, et al.
Clinical Breast Cancer|November 15, 2020
Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast CancerAkaolisa Samuel Eziokwu, Leticia Varella, Megan Lynn Kruse, et al.
Journal of Oncology Practice|June 22, 2017
Analysis of Origins of Admission for Solid Tumor Oncology Inpatients: Disease Severity and OutcomesChristopher E Wee, Lindsey M Goodman, Leticia Varella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
Increased Deaths From Fungal Infections During the Coronavirus Disease 2019 Pandemic-National Vital Statistics System, United States, January 2020-December 2021Jeremy A W Gold, Farida B Ahmad, Jodi A Cisewski, et al.
Cancer|March 15, 1988
Controlled and uncontrolled thrombocytosis. Its clinical role in essential thrombocythemiaJ J Lahuerta-Palacios, R Bornstein, F J Fernández-Debora, et al.
JTO Clinical and Research Reports|April 11, 2022
Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community PracticeNickolas Stabellini, Debora S Bruno, Mantas Dmukauskas, et al.
BMC Cancer|December 22, 2007
Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancerMatthew A Beldner, Carol A Sherman, Mark R Green, et al.
Pageof 56

Showing results (421-430 of 551) with videos related to

Sort By:
Pageof 56
Nature Medicine|June 13, 2006
Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunctionVincent Sauzeau, María A Sevilla, Juan V Rivas-Elena, et al.
Menopause (New York, N.Y.)|September 16, 1999
Models of intervention in menopause: proposal of a holistic or integral modelJ C Olazábal Ulacia, R García Paniagua, J Montero Luengo, et al.
Breast Cancer Research and Treatment|June 6, 2014
A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancerTadeu Ambros, Simon B Zeichner, John Zaravinos, et al.
Cancer Immunology, Immunotherapy : CII|August 30, 2007
Priming of naive CD8+ T cells in the presence of IL-12 selectively enhances the survival of CD8+CD62Lhi cells and results in superior anti-tumor activity in a tolerogenic murine modelC Marcela Díaz-Montero, Sabry El Naggar, Amir Al Khami, et al.
Clinical Breast Cancer|November 15, 2020
Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast CancerAkaolisa Samuel Eziokwu, Leticia Varella, Megan Lynn Kruse, et al.
Journal of Oncology Practice|June 22, 2017
Analysis of Origins of Admission for Solid Tumor Oncology Inpatients: Disease Severity and OutcomesChristopher E Wee, Lindsey M Goodman, Leticia Varella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 19, 2022
Increased Deaths From Fungal Infections During the Coronavirus Disease 2019 Pandemic-National Vital Statistics System, United States, January 2020-December 2021Jeremy A W Gold, Farida B Ahmad, Jodi A Cisewski, et al.
Cancer|March 15, 1988
Controlled and uncontrolled thrombocytosis. Its clinical role in essential thrombocythemiaJ J Lahuerta-Palacios, R Bornstein, F J Fernández-Debora, et al.
JTO Clinical and Research Reports|April 11, 2022
Sex Differences in Lung Cancer Treatment and Outcomes at a Large Hybrid Academic-Community PracticeNickolas Stabellini, Debora S Bruno, Mantas Dmukauskas, et al.
BMC Cancer|December 22, 2007
Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancerMatthew A Beldner, Carol A Sherman, Mark R Green, et al.
Pageof 56